MRC1 and neoplasm: This report represents the first molecular subtyping of UC in Lynch syndrome and despite limited in size represents a large collection of this rare tumor entity with disease‐predisposing MMR gene mutations/MMR protein loss in concordance with the germline mutation proven in 98% of the tumors.